JPRN-jRCT1031230460招募中Unknown
Comprehensive analysis of eosinophils and type 2 innate lymphoid cells in patients with severe asthma before and after mepolizumab treatment - MEISEA
Miyata Jun0 个研究点目标入组 40 人开始时间: 2023年11月19日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Other
入排标准
- 年龄范围
- >= 18age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •Patients with severe eosinophilic asthma that is defined as blood eosinophil counts >=150 cells/mm3 at enrollment and/or blood eosinophil counts >=300 cells/mm3 before the study (from the date at diagnosis of asthma to the enrollment date of this study) will be included in this study. They meet all of the following criteria.
- •- The therapeutic management using high-dose ICS (Fluticasone propionate equivalent to >=1000 microgram/day or fluticasone furan carboxylic acid equivalent to >= 200 microgram/day) and >= 2 long-term management medicines (LABA, leukotriene receptor antagonist, theophylline, or LAMA).
- •- Male and female between 18 and 80 years of age inclusive
- •- <150 kg at weight.
- •- The patient has provided written informed consent
- •Healthy volunteers will be included in this study. They meet all of the following criteria.
- •- The one has no history of specific diseases.
- •- Male and female between 18 and 80 years of age inclusive
- •- <150 kg at weight.
- •- The patient has provided written informed consent
排除标准
- •Patients are NOT eligible for this study if they met any of the following criteria:
- •- Has previously been treated with mepolizumab before the study
- •- Has a history of acute viral infection up to 4 weeks prior to blood sampling
- •- Has been treated with systemic corticosteroids including methylprednisolone up to 4 weeks prior to blood sampling
- •- History of widespread lung disease
- •- Has cancer/malignancy under treatment
- •- During the period of pregnancy
- •- Individuals whom the principal investigators judge as inappropriate registers
- •Healthy volunteers are NOT eligible for this study if they met any of the following criteria:
- •- Has a history of acute viral infection up to 4 weeks prior to blood sampling
- •- Individuals whom the principal investigators judge as inappropriate registers
研究者
相似试验
招募中
Unknown
Comprehensive analysis of eosinophils and type 2 innate lymphoid cells in patients with severe asthma before and after mepolizumab treatmentSevere asthmaJPRN-UMIN000052889Keio University40
招募中
不适用
Multi-omics analysis of Eosinophils and Neutrophils in Asthma and COPD Overlap(ACO).JPRN-UMIN000042231Keio University School of Medicine50
招募中
不适用
Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma: Influence of Systemic IL-5 TargetingAsthmaNCT05689931Region Skane80
Unknown
2 期
Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic SyndromeRespiratory System AgentsAnti-Asthmatic AgentsHematologic DiseasesLeukocyte DisordersHypereosinophiliaNCT02130882National Institute of Allergy and Infectious Diseases (NIAID)20
已完成
不适用
Data Bank for Eosinophilic DisordersEosinophilic ColitisEosinophilic GastroenteritisEosinophilic EsophagitisGastritisEnteritisNCT00267475Marc Rothenberg500